News
Medicinalgiganten Eli Lilly har skrevet under på en købsaftale med virksomheden Siteone Therapeutics. Det skriver Medwatch.
Tirsdag var der indfødsretsprøve i hele landet for over 6.000 håbefulde deltagere. Politiken har snakket med fire af dem.
Tirsdag var der indfødsretsprøve i hele landet for over 6.000 håbefulde deltagere. Politiken har snakket med fire af dem.
Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...
Novo Nordisk was Europe's most valuable company, with a big lead on obesity drugs with its runaway hits Ozempic and Wegovy.
Novo Nordisk was Europe's most valuable company, with a big lead on obesity drugs with its runaway hits Ozempic and Wegovy.
1d
Zacks Investment Research on MSNWhy Novo Nordisk (NVO) is a Top Dividend Stock for Your PortfolioGetting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent ...
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland ...
Novo Nordisk has reported new data with its long-acting human growth hormone (hGH) product Sogroya, showing it is at least as effective as its older drug Norditropin in various paediatric growth ...
Novo Nordisk was the company of 2023, soaring to the mantle of Europe’s most valuable company as its bumper weight ...
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results